Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $427000.0.

  • Neurogene's Other Non-Current Liabilities fell 3390.09% to $427000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $427000.0, marking a year-over-year decrease of 3390.09%. This contributed to the annual value of $718000.0 for FY2024, which is 2862.82% down from last year.
  • Latest data reveals that Neurogene reported Other Non-Current Liabilities of $427000.0 as of Q3 2025, which was down 3390.09% from $738000.0 recorded in Q2 2025.
  • Neurogene's Other Non-Current Liabilities' 5-year high stood at $1.0 million during Q4 2023, with a 5-year trough of $427000.0 in Q3 2025.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $728000.0 (2024), whereas its average is $730875.0.
  • Within the past 5 years, the most significant YoY rise in Neurogene's Other Non-Current Liabilities was 292.89% (2025), while the steepest drop was 3390.09% (2025).
  • Quarter analysis of 3 years shows Neurogene's Other Non-Current Liabilities stood at $1.0 million in 2023, then dropped by 28.63% to $718000.0 in 2024, then plummeted by 40.53% to $427000.0 in 2025.
  • Its Other Non-Current Liabilities stands at $427000.0 for Q3 2025, versus $738000.0 for Q2 2025 and $738000.0 for Q1 2025.